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A stem-loop termed the kissing-loop hairpin is one of the most highly conserved structures within the leader
of human immunodeficiency virus type 1 (HIV-1) and chimpanzee immunodeficiency virus genomic RNA.
Because it plays a key role in the in vitro dimerization of short HIV-1 RNA transcripts (M. Laughrea and L.
Jette´, Biochemistry 35:1589–1598, 1996, and references therein; M. Laughrea and L. Jette´, Biochemistry
35:9366–9374, 1996, and references therein) and because dimeric RNAs may be preferably encapsidated into
the HIV-1 virus, alterations of the kissing-loop hairpin might affect the in vivo dimerization and encapsidation
processes. Accordingly, substitution and deletion mutations were introduced into the kissing-loop hairpin of an
infectious HIV-1 molecular clone in order to produce viruses by transfection methods. The infectivity of the
resulting viruses was decreased by at least 99%, the amount of genomic RNA packaged per virus was decreased
by 50 to 75%, and the proportion of dimeric genomic RNA was reduced from >80 to 40 to 50%, but the
dissociation temperature of the genomic RNA was unchanged. There is evidence suggesting that the deletion
mutations moderately inhibited CAp24 production but had no significant effect on RNA splicing. These results
are consistent with the kissing-loop model of HIV-1 RNA dimerization. In fact, because intracellular viral
RNAs are probably more concentrated in transfected cells than in cells infected by one virus and because the
dimerization and encapsidation processes are concentration dependent, it is likely that much larger dimer-
ization and encapsidation defects would have been manifested within cells infected by no more than one virus.
The primer binding site and the gag gene of human immu-
nodeficiency virus type 1 (HIV-1) genomic RNA are separated
by 136 nucleotides extending from U200 to G335 in HIV-1Lai.
This 39 half of the leader is called the L sequence (14). It has
the potential to fold into three hairpins, the kissing-loop do-
main (KLD), the 59 splice junction hairpin (SD), and hairpin 3
(Fig. 1). The KLD, located in the middle of the L sequence,
encompasses a stem-loop, named the kissing-loop hairpin (nu-
cleotides [nt] 248 to 270 [Fig. 1]), seated on top of a short but
completely conserved stem-bulge (Fig. 1). In all HIV-1 and
chimpanzee immunodeficiency viruses (SIVcpz) for which pub-
lished L sequences are available, the kissing-loop hairpin is
characterized by a 7-bp stem (stem C) and an 8- to 9-nt loop
(loop C) containing the autocomplementary sequence GCGC
GC262 or GUGCAC262 (Fig. 1 and 2). Within the HIV-1/
SIVcpz lineage, the KLD seems to be the most conserved re-
gion of the L sequence (Table 1). It is better conserved, for
example, than the region centered on hairpin 3 which has been
implicated, together with other regions (7, 9, 31, 47, 59, 70), in
genomic RNA packaging (1, 11, 30, 44, 49). As the most highly
conserved sequence located halfway between the primer bind-
ing site and the AUG336 initiation codon of the gag gene and
only 30 nt upstream of the 59 splice junction, the KLDmay play
an important role in HIV-1 replication.
The kissing-loop hairpin deserves in vivo scrutiny for four
additional reasons. (i) Both mutating loop C (Fig. 1) to a
nonautocomplementary sequence (13, 67) and deleting the 59
(38) or 39 strand (39) of stem C (Fig. 1) have been shown to
annihilate the dimerization potential of HIV-1 RNA tran-
scripts coding for the first 500 to 1,000 nt of HIV-1 genomic
RNA. These findings, together with the fact that all retroviral
genomes are formed of two identical RNAs noncovalently
linked near their 59 ends (3, 4, 37, 54), strongly suggest that the
role of the kissing-loop hairpin in the in vivo genomic RNA
dimerization process should be investigated. (ii) The kissing-
loop hairpin overlaps with a region (the 241-to-253 sequence)
whose replacement by a 13-base linker appeared to reduce
genomic RNA encapsidation by 78 to 85% (Fig. 1) (33). (iii)
Since 1994, at least 14 important papers documenting a crucial
role for kissing-loop hairpins in the in vitro dimerization of
relatively short RNA transcripts from HIV-1 (13, 38–40, 51–53,
57, 58, 66, 67), Moloney murine leukemia virus (22, 23), and
avian sarcoma-leukosis virus (19) have been published. (iv) It
has been hypothesized that genomic RNA dimerization is a
prerequisite for packaging (20).
The purpose of this study was to investigate whether muta-
tions of the kissing-loop hairpin, introduced into an infectious
HIV-1 molecular clone, affect the genomic RNA dimerization
and packaging of HIV-1 viruses produced from transfected
cells. The results suggest that mutations of the kissing-loop
hairpin, though they reduce viral infectivity by at least 99%,
have moderate (but real) effects on genomic RNA dimeriza-
tion and packaging, as well as CAp24 production, but little
effect on RNA splicing. It is argued that the effect of the
mutations on dimerization and packaging in the cytoplasm of a
cell infected at the lowest possible multiplicity of infection
should be greater than that in transfected cells.
* Corresponding author. Mailing address: Lady Davis Institute for
Medical Research, 3755 Cote Ste. Catherine Rd., Montreal, Quebec
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MATERIALS AND METHODS
Buffers. Buffer TNE consisted of 20 mM Tris (pH 7.5), 100 mM NaCl, and 1
mM EDTA. Buffer L (38, 48) consisted of 50 mM sodium cacodylate (pH 7.5),
40 mM KCl, and 0.1 mM MgCl2. Buffer H (38, 48) consisted of 50 mM sodium
cacodylate (pH 7.5), 300 mM KCl, and 5 mMMgCl2. Buffer TBE2 (61) consisted
of 89 mM Tris, 89 mM borate, and 2 mM EDTA. Buffer TBM (38, 42) was the
same as buffer TBE2 with EDTA replaced by 1 mM MgCl2.
Plasmid constructions. Standard techniques were used for molecular cloning
(65), and the nucleotide positions given are those of the HIV-1Lai genomic RNA.
Plasmid pSVC21.BH10, a gift of E. Cohen, encodes an infectious molecular
clone derived from the IIIB strain of HIV-1 (18, 62). The plasmid also carries a
simian virus 40 origin of replication for expression in COS cells, which are
African green monkey kidney cells transformed by simian virus 40 (24). All the
glassware used in this study was cooked overnight, and all the H2O used for in
vitro experiments was diethylpyrocarbonate treated.
The kissing-loop hairpin of pSVC21.BH10 was altered by cassette mutagenesis
of plasmid pBH and transfer of the mutated region into pSVC21.BH10. To
prepare pBH, pSVC21.BH10 was cleaved with BglII and ApaI to extract the
18-to-1556 region of the HIV-1 genome. The BglII-ApaI fragment (BglII side
filled in) was then ligated into SacI-ApaI-digested pBluescript KS2 (38). This was
followed by digestion with NarI and BssHII to create a gap between nt 187 and
261 (the BssHII site had been blunt ended with mung bean nuclease). We then
ligated two ;70-bp duplexes into the gap created by the NarI and BssHII
digestions described above. One insert, ACS2, contains a mismatch at the top of
stem C (this shortens stem C by 1 bp and lengthens loop C by 2 nt) and has 3
mutations in loop C so that it is no longer autocomplementary (Fig. 1). The other
insert, D248-261, is self-explanatory: the 59 strand of stem C and most of loop C
are deleted (Fig. 1). (Because the HIV-1 wild-type sequence has a GC at nt 247
and 248 and nt 261 and 262, the deletion also could have been named D247-260
FIG. 1. Secondary RNA structure model for the HIV-1Lai L sequence. The cleavage site within the 59 major splice donor is marked by an arrow within the SD
hairpin. The AUG initiation codon of the gag gene is circled and somewhat arbitrarily presented as hydrogen bonded for compactness. This model is based on published
structure probing and/or phylogenetic data (2, 5, 12, 29, 31, 38, 63). The data of each group either directly support or are consistent with this model. The point mutations
introduced into the ACS2 mutant are indicated by arrows within the KLD, the nucleotides deleted in the D248-261 mutant are shown as open letters, and the first and
last nucleotides of the D241-256 mutant are numerically pointed out.
FIG. 2. Secondary structure model of the KLDs of 48 viruses from the HIV-
1/SIVcpz lineage for which published sequences of the region of interest are
available (10, 21, 55, 64, 69). When the primary structure is not completely
conserved, the number of times a given nucleotide is found at a given position is
displayed in an adjacent box divided into quadrants, one for each nucleotide.
When a nucleotide choice occurs in only one viral sequence, the name of the
sequence is indicated next to the relevant box. Because a majority of published
L sequences come from non-replication-competent strains and because sequenc-
ing mistakes are always possible (43), we judged that blind acceptance of every
nucleotide assessment would be a mistake. Forty-eight sequences, including
sequences from HIV-1 subtypes A, B, C, D, E, F, G, O, and U as well as the
sequences of all replication-competent HIV-1 strains, were accepted. Two se-
quences were somewhat arbitrarily excluded. HIV-1oyi was excluded on the basis
of its avirulence and its 6-bp stem C (32). The CxC mismatch in the middle of
stem C of HIV-13202a21 was dismissed either as a sequencing mistake or as
related to the non-syncytium-inducing character of the clone in question. (HIV-
13202a12, a syncytium-inducing clone isolated from the same patient, has a regular
stem C [26].) Finally, a mistake in the database sequence of the KLD of HIV-
1Hxb2 has previously been corrected (39). *, 6-nt-long autocomplementary se-
quence (27GCGCGC for 21GUGCAC); §, in this 3-bp box, U-R, C-G, and G-C
replaced by C-G, G-C, and A-U, respectively, in HIV-1Ant70; ‡, this 2-bp box
underwent a transition in SIVcpzant (C-G on top of a U-A instead of the oppo-
site). Covariances: YR265 has never been UG265; loop C of SIVcpzant, HIV-
1Ant70 (subtype O), and all subtype C HIV-1 viruses can form an internal base
pair, thereby lengthening stem C by 1 bp and shortening loop C by 2 nt. Y,
pyrimidine; R, purine; N, A, C, G, or U; O, N or nothing.
TABLE 1. Comparison of HIV-1Lai L-early gag sequences
a with
cognate sequences from HIV-1Ant70 (subtype O) and two SIVcpz
isolates (SIVcpzant and an isolate from Gabon [SIVcpzgab])
Hairpin or sequence
% Identityb
Rank
HIV-1Ant70 SIVcpzant SIVcpzgab Avg
AUGc 85 77 96 86 1
KLDc 77 77 89 81 1
SDc 47 63 95 68 3
PBS-KLD linkerd 77 63 60 67 3
Hairpin 3c 1 adjacent nte 58 42 65 55 5
AU-rich interhairpin regionf 44 44 67 52 5
a The L sequence extends from nt 200 to nt 335. The gag gene starts at nt 336.
The nucleotide sequence conservation of the KLD and AUG hairpin within the
HIV-1/SIVcpz lineage appears to be higher than the amino acid sequence con-
servation of any HIV-1 protein within the HIV-1 family (68).
bWith HIV-1Lai sequence.
c Depicted in Fig. 1.
d The 200-to-242 region (Fig. 1).
e The 310-to-335 region (Fig. 1).
f The 301-to-309 region (Fig. 1).
3398 LAUGHREA ET AL. J. VIROL.
or D249-262. However, the functional result is unchanged; stem C and the
autocomplementary sequence are made inoperational through complete or qua-
sicomplete destruction.) For duplex formation between the two ;70-nt comple-
mentary DNA oligonucleotides, 11 mg of each synthetic strand, dissolved in 20 ml
of buffer TNE, was incubated for 10 min at 858C in a G76 gyratory water bath
(New Brunswick Scientific) covered with a glass plate; this was followed by
shutting off water bath heating and letting the tube incubate overnight at slowly
decreasing temperature. These duplexes were phosphorylated prior to ligation.
The NarI-SpeI fragments of pBHACS2 and pBHD248-261 (i.e., the 187-to-1052
regions of the respective genomes) were then cloned into NarI-SpeI-digested
pSVC21.BH10 to yield eukaryotic expression vectors, pSVC21ACS2 and
pSVC21D248-261, respectively, containing full-length mutant HIV-1 proviral
DNA. A third mutant plasmid, pSVC21D241-256, was prepared by PCR-based
mutagenesis (46). (Because of a G at nt 241 and 257 in wild-type HIV-1,
D241-256 also could have been named D242-257.) All constructs were sequenced
to verify that the correct mutations had been achieved.
Transfections and virus preparation. Ten to 30 100- by 20-mm tissue culture
dishes of COS-7 cells were transfected with plasmids pSVC21ACS2 and
pSVC21D248-261 (10 mg/dish) by the calcium phosphate method (33). In each
transfection experiment, an equal number of tissue culture dishes was concur-
rently transfected with plasmid pSVC21.BH10 to produce the control BH10 virus
to which mutants were compared. Viruses were isolated from the Dulbecco
modified Eagle medium-fetal calf serum cell culture supernatant (7 ml/dish) at
63 h posttransfection. The supernatant was first centrifuged in a Beckman GS-6R
rotor at 3,000 rpm for 30 min, and the viruses were then pelleted from this
clarified COS-7 culture supernatant fluid by centrifugation in a Beckman Ti45
rotor at 35,000 rpm for 1 h at 48C. Unless otherwise specified, the viral pellet was
then purified by centrifugation at 26,500 rpm for 1 h at 48C through 4 ml of 15%
sucrose in buffer TNE onto a 2-ml 65% sucrose cushion in buffer TNE by using
a Beckman SW41 rotor. The average virus yield was 4 3 108 virions per dish
(assuming 2,000 capsid proteins per virion).
Infectivity assay. The numbers of 50% tissue culture infective doses (TCID50)
contained in mutant and wild-type viral preparations were measured in two
96-well flat-bottom plates as previously described (34). To perform each exper-
iment in octuplicate, each of the eight wells in the second vertical row contained
12.8 ml of clarified COS-7 culture supernatant fluid in a final volume of 200 ml of
R-20 medium containing 2 3 104 MT-4 target cells (a human T-cell line carrying
human T-cell leukemia virus type 1 [28]). The 3rd to 11th vertical rows contained
serial dilutions of the virus (from 421 to 429 dilutions). Culture fluids were
replaced at day 4 after infection. The cytopathic effects (multinucleated giant cell
formation-syncytium formation with ballooning cytoplasm) were assessed at days
4 and 7 after infection, and the number of TCID50 was calculated by the method
of Reed and Muench (16). One TCID50 is the smallest amount of virus able to
infect 50% of cell cultures at day 7, as measured by visible cytopathic effects.
Each viral infectious titer is reported as the number of TCID50/ng of capsid
protein 6 the standard error of the mean (SEM).
Physical virus titer. The physical virus titer was determined by estimating the
amount of capsid protein (CAp24) in either purified viruses or clarified COS-7
culture supernatant fluid. Clarified COS-7 culture supernatant fluid (or a virus
sample) was serially diluted (with the goal of obtaining at least one dilution
containing 3 to 20 ng of capsid protein) and assayed by using a CAp24 enzyme-
linked immunosorbent assay detection kit according to the manufacturer’s (Ab-
bott Laboratories) recommendations. The error for such measurements is 10%.
HIV-1 RNA isolation. Viruses were disrupted in 0.5 to 1 ml of sterile lysis
buffer consisting of 50 mM Tris (pH 7.4), 10 mM EDTA, 1% sodium dodecyl
sulfate (SDS), 50 mM NaCl, 50 mg of yeast tRNA per ml, and 100 mg of
proteinase K per ml (20). Resuspended pellets were incubated at 378C for 30 min
and then extracted three times with an equal volume of buffer-saturated phenol-
chloroform-isoamyl alcohol (25:24:1; pH 7.5). The aqueous phase, containing the
viral RNA, was precipitated in 70% ethanol at2808C with 0.3 M sodium acetate
(pH 5.2). Viral RNA pelleted from the ethanol suspension was dissolved in a
buffer containing 10 mM Tris (pH 7.5) and 1 mM EDTA.
Dot blot hybridization of RNA samples. The amount of genomic RNA in viral
RNA samples was quantitated by hybridization (65) with radioactive antisense
RNA 636-296, a 356-nt RNA that is antisense of the 296-to-636 region of the
HIV-1 genome. This RNA was prepared by cutting plasmid pLJ2309 with RsaI
and transcribing it with SP6 RNA polymerase in the presence of [35S]CTP or
[32P]CTP (39). Antisense RNA 636-296 had specific activities of.108 cpm/mg. A
range of 5 3 106 to 1 3 109 copies of in vitro-transcribed HIV-1 RNA 230-790
(39) was used as the standard, from which the numbers of wild-type and mutant
genomic HIV-1 RNAs were deduced. HIV-1 RNA samples were vacuum trans-
ferred to a Hybond N1 nylon membrane (Amersham, Oakville, Canada) sand-
wiched within a Hybri-Dot filtration manifold (Bethesda Research Laborato-
ries). After drying, cross-linking (0.12 J/cm2 on a UV Stratalinker 2400
[Stratagene]), and prehybridization (in 63 SSPE [13 SSPE is 0.15 M NaCl, 10
mM NaH2PO4, and 1 mM EDTA {pH 7.4}]–50% formamide–10% dextran
sulfate–1.5% SDS–53 Denhardt’s reagent–0.01% salmon sperm DNA), the ny-
lon membrane was hybridized overnight (in prehybridization buffer devoid of
Denhardt’s reagent at 428C with shaking) to approximately 107 cpm of antisense
RNA 636-296. This was followed by three washes (13 SSC [13 SSC is 0.15 M
NaCl plus 0.015 M sodium citrate]–0.1% SDS at room temperature, 0.23 SSC–
0.1% SDS at 358C, and 0.23 SSC–0.1% SDS at 458C) and autoradiography. The
autoradiograms were scanned with an LKB Ultroscan XL laser densitometer,
and to confirm the scans, the radioactivity present in each spot of the nylon
membrane was also scintillation counted.
Electrophoretic and thermal analyses of HIV-1 genomic RNA. The dimeric
nature of the encapsidated viral RNA was assessed by nondenaturing Northern
(RNA) blot analysis (20, 35) of RNA samples dissolved in buffer L and run on
1% agarose gels in buffer TBE2 at 48C or room temperature (39). We found that
running the gel at 70 V rather than our standard 95 to 100 V reduced the
smearing to a level that allows conclusive interpretations. For thermal analysis,
the RNAs were incubated at the indicated temperatures for 10 to 40 min prior
to electrophoresis. After the RNA bands had been transferred from the agarose
gel to a Hybond N1 nylon membrane (Amersham), the nylon membrane was
treated exactly as described above for the dot hybridization procedure.
Preparation and dimerization of in vitro-transcribed HIV-1 RNAs. Plasmids
pBL (39), pBHACS2, and pBHD248-261 were cleaved with AccI and transcribed
with T7 RNA polymerase to yield HIV-1 RNAs 1-508, 1-508ACS2, and
1-508D248-261, respectively, all ending at G508 (39). The dimerization proce-
dures, including attempts at preparing loose and tight dimers from the mutant
transcripts, were described previously (39, 40).
Electrophoretic analysis of spliced and unspliced viral RNAs. Total cellular
RNA extracted from COS-7 cells was purified with a commercial RNA extraction
kit (Biotecs, Houston, Tex.). The extracted RNA was treated with 100 U of
DNase I, followed by phenol-chloroform extraction and ethanol precipitation, to
ensure the removal of any contaminating plasmids and cellular DNA. The RNA
pellets were resuspended in diethylpyrocarbonate-treated double-distilled water.
RNA samples (up to 20 mg) were fractionated on 1% agarose gels containing
formaldehyde as denaturant (8). RNA molecules were transferred to a Hybond
N1 nylon membrane (Amersham) and hybridized by using pBH10 viral DNA as
a radiolabelled probe (nick translation system; Life Technologies, Toronto, Can-
ada) as previously described (8).
RESULTS
Near normal amounts of CAp24 produced after transfection
of COS-7 cells by plasmids mutated in the kissing-loop hair-
pin. To produce HIV-1 viruses mutated within the KLD,
COS-7 cells were transfected in parallel with equal amounts
of control plasmid pSVC21.BH10 and mutant plasmids
pSVC21ACS2 and pSVC21D248-261. In pSVC21ACS2, five
point mutations were introduced in loop C in order to alter its
sequence and render it nonautocomplementary (GAAGCGC
GC262 was replaced by AGAUCACUC262) (Fig. 1). In
pSVC21D248-261, the 59 strand of stem C and most of loop C
were deleted (D248-261; Fig. 1). The average amounts of
ACS2 and D248-261 viruses produced at 63 h posttransfection,
as measured by the number of capsid proteins (CAp24)
present in the culture supernatant and in the purified virus
fraction, were 85 and (55 6 15)%, respectively, of wild-type
samples (not shown). This indicates that the mutations intro-
duced had no major effect on HIV-1 genomic DNA transcrip-
tion and virus production. This is supported by the results of
recent experiments showing that the pSVC21D241-256 molec-
ular clone produced 50% 6 5% less CAp24 than did the
pSVC21.BH10 clone (46) (Fig. 1).
ACS2 and D248-261 viruses are at least 99.25 and 99.96%
less infectious, respectively, than are wild-type viruses. To
assess the infectivity of the virus produced, the numbers of
TCID50 contained in two independent preparations of ACS
2
viruses and three independent preparations of D248-261 vi-
ruses were measured. Each experiment was performed in oc-
tuplicate (see Materials and Methods). Since each experiment
involved serial dilutions, the results are best presented in log-
arithmic form (Table 2). Table 2 shows that the ACS2 and
D248-261 viruses contained 130 to 300 and 2,500 to 8,000 times
fewer TCID50 (per ng of capsid protein), respectively, than did
the wild-type virus. As an independent verification, numerous
CAp24 enzyme-linked immunosorbent assays were also per-
formed with relevant viral dilutions to confirm that physical
titers correlated with infectivity results (data not shown). Two
possible causes of this low infectivity were investigated.
Mutant viruses display a 45 to 75% reduction in encapsida-
tion efficiency. Viral genomic RNA was extracted from equiv-
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alent amounts of virus, as determined by an antigen capture
assay to detect CAp24 (see Materials and Methods). Virion
RNA was then detected by dot blot hybridization analysis with
a 35S-labeled HIV-1 riboprobe (see Materials and Methods).
The amount of HIV-1 RNA present in each spot was quanti-
tated by scanning the resulting autoradiograms and by scintil-
lation counting of the individual spots. Figures 3A and B show
that the number of genomic RNAs per unit of capsid protein
(6 SEM) of the displayed ACS2 viruses is 75% 6 6% lower
than the number of genomic RNAs per unit of capsid protein
of wild-type viruses. This value was independent of the method
of virus purification (compare Fig. 3A and B). This encapsida-
tion defect could have two explanations; the first is much more
likely than the second. Either ACS2 viruses packaged far fewer
genomic RNAs per virion, or their capsid shells contained far
more capsid proteins than normal. We do not distinguish be-
tween these two types of encapsidation deficiencies. Figure 3C
shows that the number of genomic RNAs per unit of capsid
protein (6 SEM) of the displayed D248-261 virus is 46.5% 6
2.5% lower than that in the wild-type control. It is surprising
that this physically more drastic mutation should have a
smaller effect on encapsidation. Considering all our experi-
mental results (seven dot blots for two independent ACS2
preparations and five dot blots for three independent D248-261
preparations), the final numbers of genomic RNAs per unit of
ACS2 and D248-261 capsid protein were 23.5% 6 6% and
57% 6 3%, respectively, of wild-type levels. We conclude that
mutations in the kissing-loop hairpin have moderate effects on
HIV-1 genomic RNA encapsidation and that the precise
strength of the effect may not be linearly related to the size of
the mutation. This apparent nonlinearity would be easiest to
rationalize if the KLD could interact with other regions of the
HIV-1 genome, thereby more easily allowing for suppressor
effects of some sequence changes.
Mutant viruses contain 33 to 50% less dimeric genomic RNA
than do wild-type viruses. To investigate the effects of KLD
alterations on the dimerization of HIV-1 genomic RNA, the
isolated genomic RNAs were characterized by nondenaturing
Northern analysis with a 35S-labeled HIV-1 riboprobe. Figure
4a shows that barring what seems to be RNA aggregates near
the top of the gel, there was one predominant HIV-1 RNA
species in the wild-type viral RNA sample (lane 1; its size was
that of a dimeric RNA) and two equally labeled species in the
D248-261 RNA preparation (lane 5; their sizes corresponded
to those of a monomeric RNA and a dimeric RNA). A scan of
lanes 1 and 5 (that of lane 5 was translated toward the right for
easier display) revealed that wild-type and D248-261 viral
RNAs were ;85 and ;50% dimeric, respectively (Fig. 4b). In
both wild-type and mutant samples, the dimeric RNA species
dissociated at approximately 508C (Fig. 4a, lanes 3 and 7) and
then migrated like the lower band of the mutant RNA sample,
which had the same mobility as denatured HIV-1 genomic
RNA prepared by in vitro transcription (not shown). Together,
the scans of Fig. 4 and the scans from Northern blots of two
more independent preparations of D248-261 and BH10 viruses
indicate that BH10 viral RNA was 1.75 (SEM, 60.25) times
more dimeric than was D248-261 viral RNA (not shown). Non-
denaturing Northern analysis of ACS2 HIV-1 RNAs also un-
covered a lower percentage of dimeric RNAs than that in
BH10 viral RNA samples, but because all ACS2 viral RNA
samples were more smeared as a result of having been elec-
trophoresed at 90 V (see Materials and Methods), we cannot
regard the ACS2 data as quantitative (data not shown).
Near normal splicing of viral RNA from D241-256 viruses.
The fact that the ACS2, D248-261, and D241-256 mutations
did not strongly affect virus production suggests that none of
these mutations abrogated DNA transcription from the up-
TABLE 2. Infectious titers of wild-type viruses relative to those of
mutant virusesa
Mutant Infectivity test no. LogBH10/mutant ratio Overall avg
ACS2 1 2.15 6 0.2 2.3 6 0.15
2 2.4 6 0.25
D248-261 3 3.9 6 0.25 3.65 6 0.25
4 3.2 6 0.2
5 3.85 6 0.3
a In each infectivity test, the number of TCID50 per nanogram of capsid
protein (CAp24) was determined in octuplicate by using fourfold serial dilutions
against a control BH10 population (see Materials and Methods). The data shown
were determined by the method of Reed andMuench. The SEMs are also shown.
FIG. 3. Mutant genomic RNAs are poorly encapsidated. Hybridization of
RNA dot blots with 35S-labeled antisense RNA 636-296, a 356-nt probe that is
antisense of the 296-to-636 region of the HIV-1 genome (see Materials and
Methods). (A) Comparison of BH10 viral RNA from first transfection with
ACS2 viral RNA from first transfection. (B) Comparison of BH10 viral RNA
from second transfection with ACS2 viral RNA from second transfection. (C)
Comparison of BH10 viral RNA from third and fourth transfections with D248-
261 viral RNA from third and fourth transfections. All data are normalized
relative to the numbers of capsid proteins (CAp24) and genomic RNAs in the
control BH10 viruses. These values (1a to 1h) are 2.72 3 1010 CAp24, 8.8 3 107
genomic RNAs, 5.55 3 1011 CAp24, 10.3 3 107 genomic RNAs, 2.18 3 1011
CAp24, 8.7 3 108 genomic RNAs, 3.46 3 1011 CAp24, and 18.4 3 108 genomic
RNAs, respectively. The control HIV-1 RNAs used to quantitate the amounts of
genomic RNAs in the dot blot shown in panel C are also presented. The control
HIV-1 RNA was RNA 230-790 obtained from the in vitro transcription of
plasmid pLJ230 cut with DraI (39). The number of viruses is expressed as the
number (#) of capsid proteins (CAp24). Experiment B was done with viruses
purified by pelleting in the absence of 15% sucrose and a 65% sucrose cushion
(see Materials and Methods). The amount of CAp24 was measured as described
in Materials and Methods. The amount of CAp24 per genome in wild-type virus
varies with the method used to purify the virus.
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stream long terminal repeat promoter, splicing from the down-
stream 59 splice junction, or RNA translation from the further
downstream AUG initiation codon of the gag gene. Near nor-
mal expression of CAp24 seemingly requires near normal ex-
pression and cytoplasmic accumulation of full-length viral
RNA, which itself requires near normal expression of Tat and
Rev, which are themselves translated from spliced mRNAs.
Reverse transcription (RT)-PCR assays performed with total
cellular RNA extracted from COS-7 cells transfected with
pSVC21.BH10 or pSVC21D241-256 and designed to assay for
all viral RNA made (spliced and unspliced) have shown that
the mutant plasmid produced about half the amount of RNA
produced by the control plasmid (46). In addition, chloram-
phenicol acetyltransferase (CAT) assays (performed after re-
placing the sequences downstream of nt 285 with a CAT gene
to yield plasmids D241-256-CAT and BH10-CAT) have shown
the amount of CAT produced per mutant plasmid to be 55%
6 7% lower than control values (46). The consistency among
the CAp24, CAT, and RT-PCR results suggests that the re-
duction in CAp24 production has only one cause, namely, a
transcription efficiency reduced by half, and that splicing and
translation should be hardly affected by the D241-256 muta-
tion. This is confirmed in Fig. 5, which shows, together with the
scans of the autoradiogram (not shown), that the total amount
of cytoplasmic viral RNA produced by plasmid pSVC21D241-
256 was reduced, consistent with the transcriptional defect
already demonstrated (46), and that the proportion of spliced
RNAs appeared to be reduced by an insignificant 25% in the
mutant virus.
ACS2 and D248-261 RNAs prepared by in vitro transcrip-
tion do not dimerize. HIV-1Lai RNA transcripts containing the
first 500 to 1,000 nt of the HIV-1 genome can form two types
of dimers, loose and tight dimers (39, 40, 52). Loose dimers are
formed by incubating HIV-1 RNA transcripts containing the
KLD in low- or high-ionic-strength buffer (buffer H) at 0 to
378C. Tight dimers are formed by incubating the transcripts at
55 to 608C in low-ionic-strength buffer L. Figure 6 shows that
RNAs extending to G508 and containing the ACS2 or D248-
261 mutation (lanes 2, 3, 8, and 9) do not form loose dimers
under low- and high-ionic-strength conditions. These RNAs
cannot form tight dimers either (Fig. 6, lanes 1 and 10). Bear
in mind that the RNA transcripts of Fig. 6 were studied at a
1,000-fold-higher concentration than were the genomic RNAs
of Fig. 4. The background amount of dimer (,10%) (Fig. 6,
FIG. 4. (a) Dimerization level and thermal stability of the viral RNA isolated
from equal amounts of BH10 and D248-261 HIV-1 viruses (as measured by the
number of capsid proteins). BH10 viral RNAs (3.7 3 109) and D248-261 viral
RNAs (1.9 3 109) (in a volume of 2 ml) were dissolved in a mixture of 6 ml of
water–2 ml of 53 concentrated buffer L. N (for native) samples were left on ice
for 10 min. The other samples were incubated in buffer L at the temperatures
indicated (8C) for 10 min. After incubation, all samples were loaded without
delay and with the voltage on. After electrophoresis (70 V, 4 h, 1% agarose in
buffer TBE2 at room temperature), the samples were Northern blotted, hybrid-
ized, and autoradiographed. d, dimeric RNA; m, monomer. Monomeric and
dimeric positions were confirmed with a full-length HIV-1 genome prepared by
in vitro transcription (41). The autoradiogram was exposed for 4 days. (b) Scans
of lanes 1 and 5 from panel a. For easy display, the scan of lane 5 was displaced
toward the right, relative to the scan of lane 1.
FIG. 5. Mutant intracellular viral RNA is spliced at near normal levels.
Cellular RNA was extracted from COS-7 cells after transfection with plasmid
pSVC21.BH10 (BH10) or pSVC21D241-256 (BH10-DL3). After electrophoresis
on a denaturing gel (see Materials and Methods), the samples were Northern
blotted, hybridized, and autoradiographed. MOCK, mock infected.
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lanes 1 and 10) has no biological significance. Incubations at 50
to 608C in buffer L or at 60 to 708C in buffer H of control RNAs
containing no obvious autocomplementary sequences often
give rise to such background formation of dimers (reference 39
and unpublished data). This is probably due to some stem-
loops having a melting temperature close to the incubation
temperature and occasionally switching from intrastrand to
interstrand hydrogen bonding. This artifactual dimerization
always results in the formation of between 0 and 10% dimer
(see Fig. 4 in reference 39). Incubations at 46, 49, 52, 55, 58,
and 658C for 10 to 40 min never favored the formation of more
than 10% dimeric 1-508ACS2 and 1-508D248-261 RNAs (not
shown), in accordance with the idea that this low level of
dimerization is of artifactual origin and that no hidden mean-
ing should be attached to it. Together, the in vitro data and in
vivo results suggest that a dimerization signal exists down-
stream of G508, i.e., downstream of the KLD and 39 DLS (the
39 DLS is a dimerization signal located within the early gag
coding sequence of HIV-1Mal [39, 40, 57]), but that the rate of
dimerization is controlled by the kissing-loop hairpin.
DISCUSSION
Pleiotropic effects of the kissing-loop hairpin on HIV-1
physiology or underestimation of the RNA dimerization and
packaging defect? Under the most favorable theoretical sce-
nario—monomeric genomic RNAs being encapsidated into
HIV-1 as efficiently as dimeric genomic RNAs (highly debat-
able), viruses containing only one genomic RNA being totally
avirulent (highly unlikely), and the lower dimerization level
being unrelated to the lower encapsidation levels (question-
able)—simple statistics show that if our encapsidation and
dimerization results are taken at face value, they can account
for only ;0.4% of the infectivity lost by the D248-261 viruses
and 25% of the infectivity lost by the ACS2 viruses. (It should
be recognized at the outset that such a scenario is impossibly
unrealistic; if the first assumption is true, the third one cannot
be, and mutatis mutandis, because viruses having encapsidated
one genomic RNA are bound to contain a monomeric genome
and appear to be dimerization deficient if only by default.) We
can imagine the following two nontrivial explanations for this
apparent paradox between moderate effects of the mutations
on HIV-1 formation in the cytoplasm of COS cells and massive
effects on the infection of MT-4 cells: the 248-to-261 region has
highly pleiotropic effects on HIV-1 physiology or the dimer-
ization and encapsidation data should not be extrapolated
from transfected cells to cells infected by one virus.
Because the kissing-loop hairpin is located within 30 to 80 nt
of the 59 splice junction, the primer binding site, the 59 long
terminal repeat domain, and the AUG codon of the gag gene,
it might influence RNA splicing, minus-strand DNA synthesis,
viral DNA transcription, or p55gag synthesis. We think that
RNA or DNA sequences corresponding to the kissing-loop
hairpin might stimulate viral DNA transcription by a factor of
almost 2, but we doubt that the kissing-loop hairpin signifi-
cantly influences RNA splicing, RNA translation, or minus-
strand DNA synthesis for the following reasons. (i) The trans-
fected ACS2 molecular clone produced as much CAp24 as did
the control BH10 clone; the transfected pSVC21D248-261 and
D241-256 plasmids produced 45 and (50 6 5)% less CAp24,
respectively, than did the control BH10 plasmid (see Results),
consistent with a negligible to moderate transcription defi-
ciency in these three mutants. (ii) The reduced CAp24 yield
from plasmid pSCV21D241-256 is fully explained by its re-
duced transcriptional potential (see Results). (iii) The trans-
fected pSVC21D241-256 plasmid was not significantly deficient
in splicing (Fig. 5) and displayed an ability for minus-strand
viral DNA synthesis that was at least as good as normal (45).
(iv) It is unlikely that a 25% reduction in splicing (consistent
with Fig. 5) could reduce the relative numbers of Env, Tat,
Rev, and other “accessory” proteins so much as to cause a
dramatic effect on infectivity. Otherwise, the putative Tat pro-
tein shortage would have resulted in a lower CAp24 produc-
tion than what was predicted by the CAT and RT-PCR assays
(see Results), and the lower concentration of Rev proteins
should have increased transfer time from nucleolus to cyto-
plasm, probably reducing CAp24 production. Consistent with
the above, we have found that the D241-256 mutation does not
reduce the half-life of viral genomic RNA within COS-7 cells
(46). Lastly, we have not ruled out the odd possibility that
RNA recombination (22, 23, 50), plus-strand DNA initiation,
and/or second-strand transfer might be affected by our muta-
tions; we simply note that considerable mutations within loop
C had no effect on plus-strand DNA initiation and/or second-
strand transfer and that the deletion of the whole kissing-loop
hairpin had only a moderate (66%) effect (56) (Table 3), i.e.,
nothing sufficient, even after compounding with the effects of
our mutations on viral RNA synthesis, splicing, dimerization,
and encapsidation, to explain the low infectivities of our mu-
tants. We assume that the transcription and splicing defects of
the pSVC21D248-261 plasmid are similar to or, if anything,
slightly smaller than those of the pSVC21D241-256 plasmid.
This is based on (i) their identical efficiency at producing
CAp24, (ii) the fact that the D241-256 mutation destroys more
than the kissing-loop hairpin (it also destroys the short stem on
which it is seated [Fig. 1]), and (iii) the fact that they produce
viruses which are equally noninfectious (see Results) (45).
A solution to the paradox. Faced with a dearth of simple
explanations, we propose that a substantial, if not the main,
cause of the low infectivities of our mutant HIV-1 viruses
remains their RNA dimerization and encapsidation defects,
i.e., our assays have underscored the actual level of viral RNA
dimerization and encapsidation within an MT-4 cell infected
by one HIV virus. Three elements are key to our reasoning. (i)
FIG. 6. HIV-1 RNAs mutated in the KLD and ending at G508 do not
dimerize. RNA (500 ng) was electrophoresed (10 V/cm, 70 min) at room tem-
perature on a 2.5% agarose gel containing buffer TBM. L, low-salt conditions,
i.e., incubation at 08C for 30 min in buffer L; H, incubation at 378C for 30 min in
buffer H; D, denatured sample; L 1 608 3 109, low-salt conditions followed by
heating at 608C for 10 min. d, dimeric RNA; m, monomer.
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In vitro RNA dimerization studies have always pointed out
that the RNA concentration is a critical parameter for promot-
ing HIV-1 RNA dimerization (40, 41, 48, 58). (ii) Among the
processes of RNA synthesis, splicing, translation, dimerization,
and encapsidation, the first three are unlikely to be affected by
viral RNA concentration (because they rely on interactions
with cellular components) and the fourth and fifth are likely to
be affected (because they rely on interactions between viral
components). Genomic RNA encapsidation might be concen-
tration dependent to the extent that the KLD might be an
encapsidation signal or to the extent that genomic RNA en-
capsidation might be stimulated by genomic RNA dimeriza-
tion. (iii) The number of RNA genomes per infected cell is
particularly high in massively infected or transfected cell cul-
tures because of the high multiplicity of infection or the high
level of transfected DNA per competent cell (15); in contrast,
the purpose of a TCID50 assay is to identify the lowest virus
concentration able to yield cytopathic effects in, e.g., MT-4
cells, one cytopathic effect (plaque formation) usually being
the product, with wild-type viruses, of one infectious viral par-
ticle (28). Plaque formation would require relatively massive
excesses of our mutant viruses for either of the following rea-
sons: to produce one (or a few) MT-4 cell(s) simultaneously hit
by many mutant viruses to yield an intracellular genomic RNA
concentration high enough to bypass the RNA dimerization
defect (by virtue of the law of mass action) or to produce a
massive number of infected MT-4 cells from which one or a
few will, through some stochastic effect, lead to plaque forma-
tion. In other words, a moderate reduction in the percentage of
dimeric RNA or its encapsidation level under the high intra-
cellular viral RNA concentrations of a transfected cell might
become a .99% average reduction under the (more physio-
logical) conditions of one MT-4 cell being infected by one
mutant virus; to achieve a cytopathic effect in one cell, either
intracellular mutant viral RNA concentrations must reach lev-
els similar to those found in transfected cells (achieved only
when one cell is simultaneously infected by a large number of
viruses) or, possibly, a large number of cells must adsorb vi-
ruses to increase the chance of stochastic effects which might
cause rare plaque formations. Either mechanism yields small
numbers of TCID50 per unit of mutant virus. Unfortunately,
the study of genomic RNA dimerization and encapsidation
processes under conditions where mutant HIV-1 viruses are
made to infect a normal cellular target at low multiplicities of
infection is prohibitively expensive because not enough virus is
produced to perform biochemical RNA analysis.
The kissing-loop hairpin: one element of a multipartite
dimerization and encapsidation signal. Important purposes of
the selective encapsidation process are (i) to concentrate RNA
molecules within a small volume (the viral capsid) and (ii) to
alter the composition of the packaged RNA so that it is no
longer ,1% HIV-1 RNA, as in the cytoplasm (17, 60), but is
.50% HIV-1 RNA. This requires a $100-fold increase in
packaging selectivity. The Pr55gag polyprotein offers such se-
lectivity (25), but the HIV-1 RNA sequences involved in the
necessary RNA-protein interactions are imperfectly known.
No matter what the real contribution of the KLD to the en-
capsidation process is, it is easy to imagine how the KLD,
together with the other encapsidation sites so far identified in
the U5 region (70), near hairpin 3 (Fig. 1) (1, 11, 30, 44, 49),
near the initiation codon of the gag gene (47), and further
downstream (9), could achieve a 100-fold increase in encapsi-
dation specificity or efficiency. One obvious implication of our
results and those of our predecessors is that the encapsidation
signal of HIV-1 is multipartite (see also references 7 and 49).
Genomic RNA dimerization and encapsidation: linked op-
erations? The behavior of genomic RNA isolated from our
kissing-loop-defective HIV-1 viruses is partially reminiscent of
genomic RNA isolated from protease-deficient virions (20).
First, genomic RNAs from both protease- and kissing-loop-
defective virions are dimerization deficient (20) (this study).
Second, we note that as in protease-deficient mutants, the
electrophoretic distance between monomeric and dimeric
D248-261 genomic RNAs in each RNA blot was longer (10%
longer on average) than the corresponding distance in wild-
type genomic RNA (Fig. 4b and data not shown), as if mutant
TABLE 3. Effects of mutations within the KLD on various processes
Mutation or location of
mutated nucleotides
Effect ona:
Reference
Infectivity RNAencapsidation
Genomic RNA
dimerization Splicing
CAp24
produced
after
transfection
Viral RNA
transcription
Minus-strand
DNA synthesis
Plus-strand DNA
initiation and/or
second template
transfer
D248-261 1111 1 1 ND 1 ND ND ND This study
D241-256 1111 ND ND 2 1 1 2 ND This study
Five point mutations
in 254-261
111 1 1? ND 2 ND ND ND This study
241-253 linker substitution Delayed 11b ND 2 2 ND ND ND 36
Three point mutations
in 248-251
ND 6 ND ND 2 ND ND ND 49
Three point mutations
in 257-259
11 1c 1 ND ND ND ND ND 27
D259-262 11d 1 2 ND 2 ND 2 ND 6
D248-270 1111 1e ND ND 2 ND ND 1 56
Three point mutations
in 257-259
11 1 ND ND 2 ND ND 2 56
255-263 linker substitution 111 1 ND ND 2 ND ND 2 56
a 2, no significant reduction (in most studies, no significant reduction could not exclude a 10 to 40% reduction); 6, 10 to 40% reduction; 1, 40 to 80% reduction;
11, 80 to 98% reduction; 111, 98 to 99.8% reduction; 1111, .99.8% reduction; ND, not done.
b 78 to 85% reduction in encapsidation.
c Data not originally quantitated.
d Approximate 10-fold reduction in infectivity.
e Fivefold reduction.
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dimeric genomic RNA has a less compact structure (due to the
putative inactivation of one of the wild-type interstrand link-
ages?). However, contrary to genomic RNA from protease-
deficient mutants, D248-261 genomic RNA had a wild-type
dissociation temperature (Td), 48 to 508C versus 48 to 538C for
wild-type samples (Fig. 4a and data not shown).
How can D248-261 HIV-1 genomic RNA appear to be
dimerization deficient yet as stable as the wild type? At least
two equally valid explanations can be offered. (i) Perhaps mu-
tant viruses appear to be dimerization deficient only by default,
having often encapsidated one single genomic RNA as a result
of their encapsidation defect (this model must assume that
genomic RNAs are usually monomeric at the time of encapsi-
dation or that monomeric genomic RNAs are encapsidated as
efficiently as are dimeric genomic RNAs). (ii) Perhaps the
KLD controls dimerization initiation, but another locus deter-
mines the ultimate dimer stability; therefore, genomic RNA is
slow to dimerize in the absence of an intact KLD. If wild-type
genomic RNAs dimerize mostly within the virion, then one can
imagine that the mutant genomic RNAs did not have the time
to fully dimerize by the time they were harvested. If at the
moment of encapsidation a significant proportion of wild-type
genomic RNAs are dimeric while a significant proportion of
KLD-deficient genomic RNAs are monomeric, one may fur-
ther imagine that Pr55gag polyprotein preferentially recognizes
a structural motif present only in dimeric RNAs, in addition to
incidentally exerting a twofold selectivity toward dimeric
genomic RNAs by a variant of the law of mass action (when-
ever Pr55gag catches one genomic RNA that happens to be
linked to another one, it effectively catches two genomic RNAs
in a single sweep). In this way, a dimerization defect causes an
encapsidation defect.
Our results and the previous paragraph essentially point out
that from a theoretical as well as an experimental point of view,
genome dimerization and encapsidation appear to some extent
coupled, with low encapsidation potentially leading to a deficit
in the proportion of dimeric RNAs and low rates of dimeriza-
tion potentially leading to low encapsidation. Therefore, the
KLD could play a role in the encapsidation process without
being a Pr55gag polyprotein recognition site and an encapsida-
tion signal in U5, near hairpin 3 or in the gag coding sequence,
could reduce the proportion of dimeric RNAs in the isolated
virions without being a site for interstrand linkages.
Having suggested above that the rate of genomic RNA
dimerization is determined foremost by the KLD and second-
arily by a postulated 39 dimerization signal, we further propose
that this 39 dimerization signal is located downstream of the
KLD and 39 DLS. This would explain why genomic RNAs
deprived of a correct KLD can dimerize and why short in vitro
transcripts possessing an intact 39 DLS but no KLD cannot
dimerize (Fig. 6) (40). In this respect, we have recently discov-
ered within the 39 half of HIV-1 genomic RNA a 1,000-nt-long
dimeric RNA region that has a Td of 498C (41).
Brief comparison with other studies. Relevant papers have
been published after the present experiments were nearly com-
pleted (27, 49), after several drafts of this paper had been
written (6), and after submission of the manuscript (56). Two
of them (6, 27) studied (at least in a qualitative way) the effects
of KLD mutations on viral infectivity, as well as genomic RNA
encapsidation and dimerization. A third (56) studied two of the
three parameters. Despite the numerous differences in virtu-
ally all of the experimental details (HIV-1 strains, target cells,
mutations, transfection methods, infectivity assays, and degree
of quantitation of the results) and several quantitative differ-
ences in the results, Table 3 shows that some harmony can be
found between these various studies of the effects of mutations
altering the kissing-loop hairpin (6, 27, 36, 49, 56) (this study).
This is not the place to discuss in detail the quantitative dif-
ferences between individual results. Among the scenarios de-
scribed above, one implies that in the presence of a defective
kissing-loop hairpin, in vivo dimerization occurs at a suffi-
ciently slow rate and/or with a sufficiently low association con-
stant that depending on the transfection or infection protocol,
there is room for isolated viral RNAs to range from almost
monomeric (e.g., in budding viruses from infected cells) to
entirely dimeric (e.g., in late harvest viruses from transfected
cells).
Conclusions. (i) The kissing-loop hairpin plays a role in
genomic RNA dimerization and encapsidation and has dra-
matic effects on viral infectivity; it may play a modest role in
viral RNA synthesis but does not seem to play a role in RNA
splicing or translation. (ii) The kissing-loop hairpin could be
profitably targeted by antisense constructs within an AIDS
therapeutic program. (iii) The region of the dimeric HIV-1
genomic RNA which determines its Td is not that which de-
termines the rate of dimerization. It is tempting to speculate
that in accord with the kissing-loop model of HIV-1 RNA
dimerization, the kissing-loop hairpin controls the rate of
dimerization of HIV-1 genomic RNA. (iv) The encapsidation
and dimerization processes are to some extent coupled. The
effect of the kissing-loop hairpin on one of these two processes
could be an indirect one; the cause of this indirect effect would,
however, be the direct involvement of the kissing-loop hairpin
in the other process. (v) It is not excluded that a substantial
cause of the lack of infectivity of HIV-1 viruses mutated in the
kissing-loop hairpin is the dimerization and encapsidation de-
fect shown here because of the respective differences in phys-
iology between transfected and infected cells.
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